Ahmad Yamen Arnaout

Mr. Ahmad Yamen Arnaout


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2023 in Medicine
Verified
Journal Article
Open access
AAAhmad Yamen Arnaout
Ahmad Yamen Arnaout
TATala Jouma Alhejazi
Tala Jouma Alhejazi
YNYaman Nerabani
Yaman Nerabani
OHOla Hamdan
Ola Hamdan
KAKhaled Arnaout
Khaled Arnaout
PTPRIBS Study Team
PRIBS Study Team
Dyspepsia is one of the most common chronic digestive diseases, which is due to underlying organic causes that can be detected, or causes that cannot be detected called functional dyspepsia (FD). There is no epidemiological study to date that measures the prevalence and risk factors of the FD in low- and middle-income countries, so this international cross-sectional study was conducted in 15 low- and middle-income countries from data previously published its protocol NCT05340400. Participants were recruited in the period from 22/April/2022 to 14/June/2022. The diagnosis of the FD was according to clinical manifestations. We determined the physical activity, daily stress, and fatigue of the participants. A large number of collaborators were chosen from different regions and institutions within each country to achieve diversity within the sample and reduce the probability of bias. Our study concluded that the prevalence of FD is much higher in low- and middle-income countries 37.9% [6.2%–44.2%], compared to high-income countries 10% [8%–12%], with a higher rate among the Afro-Caribbean race 47.9%. Sudan obtained the highest prevalence 44.3%, then Egypt 41.4%, while the lowest prevalence was in Algeria 25.7%. Moreover, there are many risk factors, including modifiable ones, such as severe stress, chronic fatigue, smoking, abnormal BMI, insufficient or too many hours of sleep, and previous infection with Covid-19, and non-modifiable ones such as advanced age, chronic diseases, and female sex. Highlighting the prevalence and increasing risk factors of FD in low- and middle-income countries should draw the attention of those responsible for health care in these countries and reduce the risk factors.

15 June 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
ASAziz Joseph Sabbagh
Aziz Joseph Sabbagh
KAKhaled Arnaout
Khaled Arnaout
AAAhmad Yamen Arnaout
Ahmad Yamen Arnaout
BTBayan Toutounji
Bayan Toutounji
LGLina Ghabreau
Lina Ghabreau
IAIbrahim Al-Hadid
Ibrahim Al-Hadid
Aggressive angiomyxoma is a rare benign mesenchymal tumor and occurs rarely in males. This study aimed to review all the cases of AAM in men in the English literature up to September 2020 and investigate the clinical, histochemical, and radiological characteristics of AAM and discuss the best treatment choices according to available data. A comprehensive search of the PubMed, Google Scholar, and Embase databases up to September 2020 was performed looking for reported cases of male patients with AAM. The search excluded articles in languages other than English, reported female cases, and superficial angiomyxoma cases. Among the 97 patients, the mean age was 48.2 years with an incidence peak between 40 and 60 years. The sites commonly involved were the scrotum (42.3%). On ultrasound, the tumor was hypoechoic (85.7%) with a well-defined margin (100%), whereas on MRI, most cases were isointense on T1-weighted images (53.8%), and hyperintense on T2-weighted images (85.7%). Immunohistochemistry revealed that the tumor tended to be positive for vimentin (100%), CD34 (63.4%), ER (50%), and PR (53.3%) while S-100 showed 91% negativity. Wide and complete surgical excision was conducted in most cases (72%), and follow-up duration ranged from 1 month to 144 months with a recurrence rate of 11.8%. Although the occurrence of AAM is rare in men, consideration should be taken in the differential diagnosis of a mass in the genitourinary region. According to our review, the most decisive immunohistochemistry profile is the positivity of Vimentin and CD34 with the negativity of S-100. Although hormonal treatment is controversial, we suggest a novel algorithm for the management of aggressive angiomyxoma.

3 May 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
AAAhmad Yamen Arnaout
Ahmad Yamen Arnaout
YNYaman Nerabani
Yaman Nerabani
MSMohamad Nabhan Sawas
Mohamad Nabhan Sawas
TATala Jouma Alhejazi
Tala Jouma Alhejazi
MFMohamad Ali Farho
Mohamad Ali Farho
ZAZiad Aljarad
Ziad Aljarad
Objectives The aim of this study is a descriptive presentation of cases of acute watery diarrhoea (AWD) that were presented to Aleppo University Hospital (AUH) during the recent cholera outbreak in Syria. Design Prospective, observational, cohort study. Setting and participants A total of 1061 patients with AWD were admitted to AUH during the timeframe of 20 September 2022 to 20 October 2022. The data collection was done through a structured questionnaire. This includes comprehensive clinical observation, laboratory analyses, therapeutic interventions and holistic case evaluations. Results The analysis has revealed notable insights: a predominant proportion of patients (58.6%) were residents from urban areas and 40.3% were residents from rural areas. Intriguingly, a diverse range of potential infection sources emerged from patient data within our hospital, including uncontrolled well water, vegetables and faecal-oral transmission through contaminated street/fast food. At discharge, most patients were in good health (79.7%), followed by moderate health (17.6%) and poor health (2.3%), with a minimal percentage dying before discharge (0.4%). The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%). In the follow-up period, the majority of patients exhibited good health (81.0%). Older patients (>60 years) had poorer outcomes, with 8.4% having poor health and 4.2% death rate. Conclusions The study found results consistent with previous AWD outbreaks in developing countries like Yemen, Nigeria and Lebanon. Preventative measures like improving water sanitation and hygiene practices are essential to prevent future outbreaks and ease the strain on healthcare systems. Therefore, future studies must investigate the risk factors that increase the spread and the severity of the disease and investigate the best management method.

13 December 2025 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
AAAhmad Yamen Arnaout
Ahmad Yamen Arnaout
AAAbdallah Aladna
Abdallah Aladna
RKReem Kozum
Reem Kozum
RMRaghad Makki
Raghad Makki
ASAhmad Sabouni
Ahmad Sabouni
AAAbdulsalam Amino
Abdulsalam Amino
A common treatment for coronary artery disease is CABG, which often involves the use of saphenous veins or internal mammary arteries as grafts. The selecte

31 May 2023 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
PDF file
AAAhmad Yamen Arnaout
Ahmad Yamen Arnaout
YNYaman Nerabani
Yaman Nerabani
HAHassan Alhaj Ali
Hassan Alhaj Ali
MSMohamad Zaher Shahrour
Mohamad Zaher Shahrour
MFMohamad Yahia Fallaha
Mohamad Yahia Fallaha
HAHussein Al-Kanj
Hussein Al-Kanj
Background. In the Norwood procedure, a conduit is performed either from the subclavian artery to the pulmonary artery, BlalockTaussig shunt (mBTs), or from the right ventricle to the pulmonary artery (RV-PA shunt). There are some concerns regarding the two shunts and which one is better according to morbidity and mortality in patients with hypoplastic left heart syndrome or its variants. Methods. We systematically searched PubMed, Web of Science, Scopus, Embase, and Cochrane Library databases from inception to 04/June/2021 to collect articles reporting a comparison of RV-PA shunt and mBTs. Results. Our meta-analysis showed that the mortality rate after 6months, 1, 2, 3, 4, 5, and 6years for the mBTS group was 16.3, 28.6, 34.8, 42.4, 44.6, 45.1, and 39.6, respectively, and for the RV-PAS, 14.8, 26.6, 31, 40.1, 36.1, 37.5, and 34.0, respectively. The mortality rate was significantly higher in the mBTs group at 1 and 2years; otherwise, there is no significance differences. Overall complications rate was higher in the mBTs group than in the RV-PAs group (17.8 vs. 8.5). In contrast, the rate of cardiac complications was higher in the RV-PAS group. Conclusions. The RV-PA shunt had lower mortality and overall complications rate than mBT shunt at the short-term outcome within the first two years, but at the long term, there was no difference between the two shunts. On the other hand, the mBT shunt had a lower incidence of cardiac complications at the early stage after the operations. However, some studies are poor due to the difficulties in conducting original research in this field. Therefore, we recommend conducting systematic reviews and original studies to compare these and other therapeutic procedures for these patients.

8 December 2025 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
BSBaraa Shebli
Baraa Shebli
MGMike Ghabally
Mike Ghabally
MSMuhammad Besher Shabouk
Muhammad Besher Shabouk
AAAhmad Yamen Arnaout
Ahmad Yamen Arnaout
MZMohamed Besher Zeina
Mohamed Besher Zeina
MMMahmoud Malhis
Mahmoud Malhis
Background: Beta-agonists like Levalbuterol and Albuterol are used in the treatment of Hyperkalemia. However, few studies in the medical literature have directly compared the cardiac effects and potassium-lowering efficacy of levalbuterol and albuterol, yielding inconclusive results. Understanding the cardiovascular effects and potassium-lowering abilities of these medications in hyperkalemic patients is crucial for optimizing treatment strategies and minimizing adverse events. Methods: This randomized controlled trial conducted at Aleppo University Hospital in Syria aimed to compare the cardiovascular and potassium-lowering effects of Levalbuterol vs. Albuterol in hyperkalemic patients. The study, carried out between October 2021 and February 2022, utilized a single-center single-blinded two-armed design with patients randomized using a computer-generated sequence and block randomization method. Results: The results showed no significant difference in mean HR change between Levalbuterol and Albuterol groups at 30 min, nor in the change in potassium serum levels at 90 min. Both drugs exhibited similar patterns in HR changes over time and blood pressure variations at different points. Despite limitations in data collection for side effects, the reported symptoms in both groups were consistent with known side effects of beta-agonists, with tremors and nervousness being the most commonly reported. Conclusion: Our study provides the first direct insights into the effects of Levalbuterol and Albuterol on heart rate, potassium levels, and blood pressure which would be very important in specific cases such as in patients with heart failure. Both medications showed similar patterns in heart rate changes, potassium levels, and blood pressure variations at different time points. Clinical Trial Registration: Clinicaltrials.gov , identifier NCT05173584.